CCIA
BLUE

Campbell & Co Investment Adviser’s bluebird bio BLUE Stock Holding History

Campbell & Co Investment Adviser’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-370
Closed -$292K – 383
2020
Q2 		$292K Buy
+370
New +$279K 0.37% 108

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Campbell & Co Investment Adviser's BLUE Position: Q3 2020 in Review

Campbell & Co Investment Adviser sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 370 shares — an estimated $292K sold.

Campbell & Co Investment Adviser first reported a position in BLUE in Q2 2020 and held it in 1 quarter. The position peaked at $292K in Q2 2020. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

  • Campbell & Co Investment Adviser reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 370 bluebird bio shares in Q3 2020, an estimated $292K.
  • Campbell & Co Investment Adviser first reported a position in bluebird bio in Q2 2020 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's bluebird bio position peaked at $292K in Q2 2020.
  • 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2020, filed 15 Oct 2020.